SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
Email Signup | RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Del Coso J, Hiam D, Houweling P, Pérez LM, Eynon N, Lucia A. Eur. J. Appl. Physiol. 2019; 119(1): 49-60.

Affiliation

Universidad Europea de Madrid (Faculty of Sport Sciences) and Research Institute i+12, Madrid, Spain.

Copyright

(Copyright © 2019, Holtzbrinck Springer Nature Publishing Group)

DOI

10.1007/s00421-018-4010-0

PMID

30327870

Abstract

A common null polymorphism (rs1815739; R577X) in the gene that codes for α-actinin-3 (ACTN3) has been related to different aspects of exercise performance. Individuals who are homozygous for the X allele are unable to express the α-actinin-3 protein in the muscle as opposed to those with the RX or RR genotype. α-actinin-3 deficiency in the muscle does not result in any disease. However, the different ACTN3 genotypes can modify the functioning of skeletal muscle during exercise through structural, metabolic or signaling changes, as shown in both humans and in the mouse model. Specifically, the ACTN3 RR genotype might favor the ability to generate powerful and forceful muscle contractions. Leading to an overall advantage of the RR genotype for enhanced performance in some speed and power-oriented sports. In addition, RR genotype might also favor the ability to withstand exercise-induced muscle damage, while the beneficial influence of the XX genotype on aerobic exercise performance needs to be validated in human studies. More information is required to unveil the association of ACTN3 genotype with trainability and injury risk during acute or chronic exercise.


Language: en

Keywords

Athletic performance; Common human polymorphism; Genomics; Muscle performance; α-Actinin-3 deficiency

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print